Model
Edge
Nabriva Therapeutics
0001693064
Filing Type
4
Filing Date
12/1/2022
Updated
12/2/22, 10:17 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership